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Voiding Dysfunction
Rethinking Suprapubic Cystostomy in Voiding Dysfunction: New 
Trial with Timed Drainage
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Department of Urology, Bundang Jesaeng Hospital, Seongnam, Korea
Purpose: Today, many patients with voiding dysfunction select suprapubic cystostomy 
(SPC) instead of clean intermittent catheterization (CIC) for practical reasons. There 
is thus a need to reconsider SPC as a management for voiding dysfunction. We designed 
SPC with timed drainage (TSPCD) and evaluated its effectiveness compared with con-
tinuous drainage with a urine bag (CSPCD).
Materials and Methods: Between January 2006 and January 2010, a total of 82 patients 
underwent SPC. Patients undergoing SPC were randomly assigned to CSPCD or 
TSPCD. Patient characteristics, complications, and the results of urine cultures were 
compared between the two groups through retrospective chart reviews. Also, prefer-
ences for CSPCD and TSPCD in another 15 patients who had experienced both CSPCD 
and TSPCD were investigated.
Results: The CSPCD and TSPCD groups comprised 46 and 36 patients, respectively. 
In a comparison of complications between the two groups, the incidence of acute sympto-
matic cystitis was significantly lower in the TSPCD group than in the CSPCD group 
(43% vs. 20%, p=0.032). The incidence of symptomatic urinary tract infection (UTI) was 
lower in the TSPCD group. Positive urine culture rates were 89.7% and 72.4% in groups 
1 and 2, respectively. There was a significant difference between the two groups (p= 
0.004). In another 15 patients who experienced both CSPCD and TSPCD, 14 patients 
(93%) stated a preference for TSPCD after converting from CSPCD to TSPCD, and one 
patient (7%) returned to CSPCD only at night.
Conclusions: In this study, TSPCD had the advantages of less morbidity as UTI and 
being more preferable by patients with relatively good daily activity compared with 
CSPCD. TSPCD is an alternative to CSPCD for the treatment of voiding dysfunction.
Key Words: Cystostomy; Dysfunction; Urinary bladder
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial 
License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, 
distribution, and reproduction in any medium, provided the original work is properly cited.
Article History:
received 1 September, 2010
accepted 15 October, 2010
Corresponding Author:
Jeong Hwan Son
Department of Urology, Bundang 
Jesaeng Hospital, 255-2, 
Seohyeon-dong, Bundang-gu, 
Seongnam 463-774, Korea
TEL: +82-31-779-0165
FAX: +82-31-779-0929
E-mail: sjhwany@hanmail.net
INTRODUCTION
Today, the prevalence of voiding dysfunction has increased. 
One of the reasons for this increasing prevalence is the ag-
ing of modern society. Aging people have many underlying 
diseases such as diabetes mellitus, cardiac disease, and ce-
rebral infarction that can cause voiding dysfunction. An-
other reason for the increasing incidence is the increasing 
risk of disability due to trauma in everyday life.
　The optimal method of bladder management for voiding 
dysfunction should preserve renal function and minimize 
urinary tract complications. Additionally, patients’ com-
fort, convenience, and quality of life are important factors 
to be considered. Bladder management alternatives in-
clude clean intermittent catheterization (CIC), urethral 
indwelling catheter, suprapubic cystostomy (SPC), and 
urethral sphincterotomy [1,2].
　With the introduction of CIC by Lapides et al, CIC revolu-
tionized the management of voiding dysfunction [3]. 
Published guidelines regard CIC as the gold standard for 
the bladder management of voiding dysfunction [4-6]. 
However, many patients with voiding dysfunction select Korean J Urol 2010;51:847-852
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FIG. 1. Longitudinal changes in bladder management for voiding
dysfunction in this study. SPC: suprapubic cystostomy, CIC: 
clean intermittent catheterization.
an indwelling catheter instead of CIC for various reasons 
such as failure of CIC, irreparable urethral damage, pro-
gression of the original disease, failure of Crede’s maneu-
ver, lack of a caregiver to aid with this technique, or poor 
upper extremity dexterity [1,7-9].
　Considering that many patients with voiding dysfunc-
tion currently select SPC, there is a need to find ways to 
reduce SPC-related complications and to make this daily 
activity more convenient. We have therefore designed a 
new trial called SPC with timed drainage (TSPCD).
MATERIALS AND METHODS
This study was intended for patients who underwent and 
maintained SPC because of voiding dysfunction for more 
than 6 months from January 2006 to January 2010.
　Patients with voiding dysfunction and their caregivers 
were initially advised to perform CIC after training. After 
the patients or caregivers had practiced CIC by themselves 
for 7 days, they made their decision as to whether to con-
tinue CIC or switch to another method. If they wanted to 
continue CIC, they were closely monitored through the out-
patient clinic. If they could not continue CIC and wanted 
to switch to another method, SPC was offered. During the 
diagnostic workup, patients who had any upper urinary 
tract abnormality, vesicoureteral reflux, or upper spinal 
cord injury that caused detrusor hyper-reflexia were ex-
cluded because we did not think that TSPCD could be ap-
plied in those cases. Inclusion criteria in the urodynamic 
study were detrusor areflexia, detrusor underactivity, and 
voiding dysfunction patients who had more than 70% re-
sidual urine. At the time of diagnosis, a total of 114 patients 
were completely educated about CIC. Among them, 56 pa-
tients wanted to switch to another method immediately af-
ter starting CIC. Additionally, 26 patients underwent SPC 
later in the course of monitoring through the outpatient 
clinic (Fig. 1). In total, 82 patients underwent SPC and were 
included in this study.
　Patients who underwent SPC were randomly assigned 
to continuous drainage with a urine bag (continuous supra-
pubic cystostomy drainage, CSPCD; group 1) or timed 
drainage at 4-5-hour intervals through a stopper applied 
on the catheter without a urine bag (TSPCD: timed supra-
pubic cystostomy drainage, group 2). During the above peri-
od, TSPCD was prescribed by one clinician; another clini-
cian prescribed only CSPCD. The SPC catheter was routinely 
changed every 4 weeks, and incidental changes were made 
in the case of any catheter-related symptoms and signs. For 
urine analysis and urine cultures, the first drained urine 
immediately after SPC catheter change was collected. Each 
time the catheter was changed, the patients were reminded 
to perform bladder irrigation twice per week. There were 
no routine uses of anticholinergics or antibiotics in this study. 
　Symptomatic urinary tract infection (UTI) was defined 
by any clinical symptoms and signs (fever, chill, suprapubic 
pain, flank pain, painful scrotal swelling, etc.) with positive 
urine culture.
　Patient characteristics including World Health Organi-
zation (WHO) performance scores and urodynamic param-
eters, complications, urine analysis, urine cultures, and 
changes in serum creatinine for the two groups were inves-
tigated through retrospective chart reviews.
　Also, preferences for CSPCD and TSPCD in another 15 
patients who had experienced both CSPCD and TSPCD 
were investigated. The patients were questioned as to why 
they preferred each method.
　For statistical analysis, the Statistical Package for the 
Social Sciences SPSS ver. 15 (SPSS Inc., Chicago, IL, USA) 
program, Student’s t-test, chi-square test, and Fisher’s ex-
act test were used. Also, the paired t-test was used for 
changes in urine pH and serum creatinine. Significance 
was accepted at p-values of less than 0.05.
RESULTS
Group 1 comprised 46 patients, with a mean age at the time 
of SPC of 70.6 years (range, 47-89 years) and a mean fol-
low-up interval of 23.1 months. Group 2 comprised 36 pa-
tients with a mean age at the time of SPC of 62 years (range, 
49-93 years) and a mean follow-up interval of 21.4 months. 
Patient characteristics including mean WHO performance 
status score and baseline urodynamic parameters were not 
significantly different between the two groups (Table 1). 
The indications for SPC are shown in Table 2. The most 
common indication in this study was diabetic cystopathy.
　Table 3 shows the incidence of urological complications 
in the two groups. Since SPC, 72 episodes of urological com-
plications occurred in 27 patients of group 1, and 31 epi-
sodes of urological complications occurred in 12 patients of 
group 2. The incidence of acute symptomatic cystitis in 
group 2 was significantly lower than in group 1 (43% vs. 
20%, p=0.032). Also, the incidences of the other complica-
tions were higher in group 1 than in group 2 except for epi-
didymoorchitis, although these differences were not signi-Korean J Urol 2010;51:847-852
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TABLE 1. Characteristics of the patients in the two groups
　 Group 1 (CSPCD) Group 2 (TSPCD)
p-value
　 Mean±SD Range Mean±SD Range
No. of patients 46 36
Sex ratio (male:female) 1.8:1 1.7:1 0.114
a
Mean age (yr) 70.6±9.7 47-89 62±8.9 49-93 0.267
b
Mean follow-up (mo) 23.1±10.1 6-34 21.4±9.9 6-35 0.187
b
Mean WHO performance scores 1.61±0.75 1-3 1.51±0.69 1-3 0.366
b
Baseline urodynamic parameters
　Maximal capacity (ml) 614.3±135.3 335-680 710.3±119.6 352-790 0.121
b
　Compliance (ml/cmH2O) 70.2±21.6 14.2-90.4 72.7±22.3 15.6-89.5 0.392
b
　Qmax (ml/s) 2.7±3.5 0-8.7 2.9±3.3 0-7.6 0.457
b
　Pdet at Qmax (cmH2O) 5.9±8.1 0-24 6.4±8.9 0-27 0.434
b
　Voided volume (ml) 36.4±46.9 0-112.5 34.9±47.5 0-108.9 0.460
b
　PVR (ml) 599.8±157.6 309-680 676.9±141.8 336-790 0.173
b
CSPCD: continuous suprapubic cystostomy drainage, TSPCD: timed suprapubic cystostomy drainage, WHO: World Health Organiza-
tion, Qmax: maximal flow rate, Pdet at Qmax: detrusor pressure at maximal flow rate, PVR: postvoid residual, 
a: chi-square test, 
b:
Student’s t-test
TABLE 2. Indications for SPC in the two groups
Diagnosis
No. of patients (%)
Group 1 (CSPCD) Group 2 (TSPCD)
Diabetic cystopathy 19 (41.4) 15 (41.6)
Inoperable benign prostatic hyperplasia 11 (23.9) 9 (25)
Cerebrovascular accident   7 (15.3)   8 (22.2)
Lower spinal cord injury  3 (6.5) 2 (5.6)
Parkinsonism 2 (4.3) 1 (2.8)
Spinal stenosis 2 (4.3) 1 (2.8)
Prostate cancer 2 (4.3) 0
Total 46 (100) 36 (100)
SPC: suprapubic cystostomy, CSPCD: continuous suprapubic cystostomy drainage, TSPCD: timed suprapubic cystostomy drainage
TABLE 3. Urological complications in the two groups
Complications
Group 1 (CSPCD) Group 2 (TSPCD)
p-value
No. of patients (%) No. of episodes  No. of patients (%) No. of episodes 
Acute cystitis (symptomatic) 20 (43) 35 7 (20) 12   0.032
a,b
Acute pyelonephritis 5 (11) 9 1 (2) 2 0.178
c
Catheter blockage 7 (15) 10 5 (14) 7 0.561
c
Urethral leakage 3 (6) 6 2 (5) 4 0.628
c
Bladder stone 4 (8) 6 1 (2) 2 0.382
c
Skin infection 3 (6) 4 3 (8) 3 0.542
c
Sepsis 2 (4) 2 0 0 0.316
c
Epididimo-orchitis 0 0 1 (2) 1 0.447
c
Total 27 72 12 31 　
CSPCD: continuous suprapubic cystostomy drainage, TSPCD: timed suprapubic cystostomy drainage, 
a: chi-square test, 
b: p＜0.05,
c: Fisher’s exact test
ficant. Total episodes of complications were greater in 
group 1 than in group 2, numbering 72 and 31 in groups 1 
and 2, respectively. In particular, the incidences of bladder 
stone and sepsis, which were serious complications and re-
quired careful management, were much higher in group 1 
than in group 2. But, these differences were not statisti-
cally significant (p=0.382, p=0.316).
　Table 4 shows the outcome of the urine cultures in both Korean J Urol 2010;51:847-852
850 Park et al
TABLE 4. Urine culture results in the two groups
Microorganisms
a No. of positive urine cultures (≥10
5 CFU/ml)
p-value
b
Group 1 (CSPCD) Group 2 (TSPCD)
Gram-negative 77 39
　Pseudomonas aeruginosa 8 3
　Escherichia coli 10 4
　Klebsiella pneumoniae 7 2
　Proteus species 3 1
　Enterobacter species 2 2
　Acinetobacter species 10 3
　Stenotrophomonas 8 8
　Citrobacter species 13 6
　Serratia species 11 6
　Burkholderia species 5 4
Gram-positive 19 11
　Staphylococcus aureus 3 1
　Enterococcus species 2 1
　Candida species 10 7
　Trichosporon species 4 2
Total 96 50 　
Positive urine culture rate 89.7% (96/107) 72.4% (50/69) 0.004
c
CSPCD: continuous suprapubic cystostomy drainage, TSPCD: timed suprapubic cystostomy drainage, CFU: colony-forming unit, 
a: 
the dominant microorganism is presented for cases of multiple microorganisms, 
b: chi-square test, 
c: p＜0.05
groups. A total of 107 and 69 urine cultures were done in 
groups 1 and 2. Positive urine culture rates were 89.7% 
(96/107) and 72.4% (50/69) in groups 1 and 2, respectively. 
More bacteriuria developed in group 1 than in group 2, and 
the difference was statistically significant (p=0.004). Con-
cerning the outcomes of urine cultures, 77 and 39 g negative 
bacterial cultures were isolated in groups 1 and 2, respec-
tively. More gram-negative than gram-positive bacteria 
were isolated from urine in both groups.
　In group 1, urine pH levels before SPC and at least 6 
months after SPC were 6.21±0.17 and 6.51±0.34 (p=0.096), 
respectively; in group 2, these values were 6.65±0.25 and 
6.72±0.41 (p=0.066), respectively. In group 1, serum crea-
tinine levels before SPC and at least 6 months after SPC 
were 1.17±0.08 and 1.27±0.11 (p=0.058), respectively; in 
group 2, these values were 1.26±0.19 and 1.06±0.14 (p= 
0.072), respectively. There were no significant changes in 
urine pH or serum creatinine in the two groups.
　In the investigation of preferences for CSPCD and 
TSPCD, from a group of 15 patients who had experienced 
both CSPCD and TSPCD, 14 patients (93%) expressed a 
preference for TSPCD because of greater convenience for 
daily activity after converting from CSPCD to TSPCD. One 
patient (7%) returned to CSPCD only at night because of 
nighttime awakening for drainage. Most of the patients 
showed relatively good daily activity (1.53±0.74) according 
to WHO performance status.
DISCUSSION
CIC is still considered the ideal management for voiding 
dysfunction if the patient is willing and is physically and 
mentally able to perform the task or has caregivers who are 
able to assist [4-6]. This is due to the increasing possibility 
of complications associated with indwelling catheter-
ization compared with CIC, such as UTI, renal failure, 
bladder and ureter stones, urethral fistulas, strictures and 
erosions, and bladder cancer [9-12].
　However, at present, SPC is often used to treat voiding 
dysfunction because of its purported benefits and con-
venience. Cameron et al reported a trend that during fol-
low-up, 80% of spinal cord injury patients on CIC switched 
to an indwelling catheter [9]. These trends reflect the fact 
that CIC requires additional effort that may not be feasible 
for certain patients in the long term [9]. In this study, 49% 
of the patients (56/114) gave up CIC immediately after 
starting CIC, and 23% of the patients (26/114) switched 
from CIC to SPC in the outpatient clinic after less than 1 
year. Only 28% of the patients (26/114) who initially started 
CIC maintained it, even though this was a short follow-up. 
The reasons for selecting SPC immediately after starting 
CIC were patient unwillingness, poor performance, and 
mental retardation. Reasons for switching to SPC during 
maintenance of CIC included severe damage to the ure-
thra, worsening of general condition, persistent incon-
tinence, and recurrent epididymitis (Table 5). The main 
reason for selecting SPC was patient unwillingness. The 
result reflects the characteristics of modern society, such 
as the nuclear family, the graying of society, and an increas-
ing desire for independent social activity and daily life.
　SPC often causes UTIs such as acute cystitis, acute pyelo-
nephritis, epididymoorchitis, and even sepsis. Also, SPC can Korean J Urol 2010;51:847-852
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TABLE 5. Reasons for selecting SPC instead of CIC
Causes No. of patients
Immediately after starting CIC 56
　Patients’ unwillingness 37
　Poor performance  17
　Mental retardation  2
During maintenance of CIC 26
　Severe damage to urethra  14
　Worsening of general condition 6
　Patients’ unwillingness 3
　Persistent incontinence 2
　Recurrent epididymitis  1
Total  82
SPC: suprapubic cystostomy, CIC: clean intermittent catheter-
ization
cause complications such as blocking of the catheter, ure-
thral leakage, bladder stone, and skin infections [1,2,7-14]. 
However, there was little increase in the risk of complica-
tions with SPC compared with CIC in a recent review of con-
temporary management in which antimuscarinics, fre-
quent catheter changes, and bladder washes were used 
[1,2,7,8].
　In light of these recent trends and practical views, it is 
necessary to be concerned about how to reduce SPC-related 
complications. With reduced complications, it is possible to 
present patients with a more convenient and safe voiding 
method. In this study, we designed TSPCD as a method that 
can maintain a physiologic and periodic bladder filling and 
emptying cycle and thus reduce the chance of ascending in-
fection via the urine-collecting bag. We found that the in-
cidences of UTI and bacteriuria were reduced with TSPCD.
　Bacterial adherence to the uroepithelium is recognized 
as an important mechanism in the initiation and patho-
genesis of UTI. There are several anti-adherence mecha-
nisms of UTI, which include the normal bacterial flora, uri-
nary oligosaccharides, uromucoids, bladder mucopoly-
saccharides, and urinary immunoglobulins, for example. 
Also, exfoliation of infected epithelial cells and the mechan-
ical effect of flushing during bladder emptying and peri-
stalsis play most important roles in the anti-adherence 
mechanism [15].
　Regarding anti-adherence mechanisms, TSPCD has an 
effect of maintaining the natural mechanical washout ef-
fect during bladder emptying and peristalsis. This effect 
will be helpful to increase the excretion of infected epi-
thelial cells and reduce the chances for bacterial coloni-
zation. Since the introduction of closed drainage systems, 
the incidence of catheter-associated UTI via ascending 
routes has been reduced. Barford et al reported in an ex-
perimental model that most bacteria gain access to the 
bladder along the outside of the catheter [16]. However, 
their study included data from a short period of up to 5 days. 
They commented that after 4 days significant bacterial 
growth appeared on the inside of the catheter, and after 
long periods, more bacteria can grow inside than outside, 
which might be due to the absence of immune cells or simply 
more nutrients in the urine [16]. Therefore, getting rid of 
the urine bag in cases of a long period catheterization could 
reduce the chances of bacterial colonization and further as-
cending infection via the urine bag. TSPCD in comparison 
with CSPCD, in which the indwelling catheter is always in 
direct contact with the contracted bladder mucosa, can re-
duce bladder mucosal damage by diminishing the direct 
contact between the bladder mucosa and the indwelling 
catheter. As a result, TSPCD is helpful for maintaining the 
innate mucosal immune system of the bladder.
　The rate of bacteriuria in this study was higher in group 
1 than in group 2 (89.7% vs 72.4%). We found a lower rate 
of positive urine cultures in the TSPCD group than did 
Kang and Choi (72.4% vs 92.7%) [17]. This result reflects 
the fact that TSPCD was associated with fewer colonized 
microorganisms than CSPCD. This result can also be ex-
plained by the reasons previously discussed above.
　SPC results in a high patient satisfaction rate according 
to the following literature. The most recent and largest ret-
rospective analysis by Ahluwalia et al examined 219 pa-
tients with SPC catheters over 50 months [18]. Overall, 
with the use of an invalidated questionnaire, their patient 
cohort had a satisfaction rating of 71% [18]. Sheriff et al also 
reported a high satisfaction rate with the use of an invali-
dated questionnaire [19]. Of their patients, 99% and 70% 
reported a 7/10 and 9/10 satisfaction score, respectively. 
Also, 82% of their patients reported that SPC insertion had 
positively improved their quality of life and 79% would 
strongly recommend this type of long-term bladder drain-
age to other patients [19].
　In this study, although satisfaction between the two 
groups was not compared by use of a validated ques-
tionnaire, a preference for TSPCD in relation to the con-
venience of daily activity was shown.
　Our study had limitations in that it was a retrospective 
study in one medical center and had a relatively small size, 
but we saw encouraging results for symptomatic UTI with 
the new trial. Because of the relatively short-term fol-
low-up, the evidence from our study concerning the in-
cidence of complications other than symptomatic UTI may 
have been weak. Therefore, additional prospective, rando-
mized trials are needed to ascertain the effectiveness of 
TSPCD. Future research that includes urodynamic fol-
low-up, upper tract function follow-up, and comparison of 
satisfaction between CSPCD and TSPCD by validated 
questionnaire would be able to more clearly ascertain the 
effectiveness of TSPCD. Another weakness of this study is 
that the patients included had relatively good daily 
activity. Their relatively good daily activity may have af-
fected their preference for TSPCD. Further studies of pa-
tients with poor daily activity, such as those with higher 
spinal cord injury or severe cerebrovascular sequelae, 
would be meaningful.Korean J Urol 2010;51:847-852
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CONCLUSIONS
CIC is still considered the ideal management for voiding 
dysfunction. Nevertheless, SPC is currently more fre-
quently used owing to its convenience and the increased 
failure of CIC. Also, recent retrospective series about com-
plication rates for SPC compared with CIC have demon-
strated clinically acceptable results. Therefore, SPC can be 
considered as an appropriate option for voiding dysfunction. 
In these circumstances in which SPC is generally accepted 
as a treatment method, there is a need to focus on ways to 
reduce the complications related to SPC.
　In this preliminary study, we found that TSPCD had the 
advantages of less morbidity as UTI and being more pref-
erable to patients with relatively good daily activity com-
pared with CSPCD. TSPCD can be considered as an alter-
native to CSPCD for the treatment for voiding dysfunction, 
even though more research on this method is needed.
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